# AbbVie clinical trials: 977 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 977 trials with AbbVie as lead sponsor, 125 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by AbbVie: 977 rows for $48.85, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 8 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/abbvie

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 977
- Recruiting or not yet: 125
- Read on: November 19, 2026

## Trials

The 25 newest of 977, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07935564 | A Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants. | AbbVie | Phase 1 | Not yet recruiting | Healthy Volunteer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935564) |
| November 12, 2026 | NCT07933536 | A Study to Assess Targeted Therapies for Treatment of Adults With Moderate to Severe Psoriasis | AbbVie | Phase 2 | Not yet recruiting | Moderate to Severe Psoriasis | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933536) |
| November 12, 2026 | NCT07933497 | M4 Receptor PET Radioligand Validation Study in Healthy Adults | AbbVie | Early phase 1 | Not yet recruiting | Healthy Volunteers | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933497) |
| November 12, 2026 | NCT07933211 | A Study to Evaluate the Safety and Efficacy (How Well the Study Treatment Works) of ABBV-2294 in Adult Participants With Systemic Sclerosis... | AbbVie | Phase 2/3 | Not yet recruiting | Systemic Sclerosis | 580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933211) |
| November 9, 2026 | NCT07925983 | A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants | AbbVie | Phase 1 | Recruiting | Healthy Volunteer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925983) |
| October 29, 2026 | NCT07904754 | Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis | AbbVie | Phase 2 | Not yet recruiting | Rheumatoid Arthritis | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904754) |
| October 27, 2026 | NCT07896434 | A Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental Vitiligo | AbbVie | Phase 3 | Not yet recruiting | Non-Segmental Vitiligo | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896434) |
| October 27, 2026 | NCT07896421 | Real-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and... | AbbVie | Observational | Recruiting | Platinum-Resistant FRα-Positive Ovarian Cancer, Platinum-Resistant FRα-Positive Fallopian Tube Cancer... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896421) |
| October 26, 2026 | NCT07895056 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and... | AbbVie | Phase 2 | Not yet recruiting | Extensive Stage-Small Cell Lung Cancer | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895056) |
| October 26, 2026 | NCT07895043 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and... | AbbVie | Phase 2 | Not yet recruiting | Extensive Stage-Small Cell Lung Cancer (ES-SCLC) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895043) |
| October 19, 2026 | NCT07880756 | Safety and Effectiveness of NOA HYDRATION Injectable Gel for the Improvement of Skin Quality Including Attributes Such as Skin Smoothness | AbbVie | Phase 3 | Recruiting | Skin Quality | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880756) |
| October 13, 2026 | NCT07871513 | A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With... | AbbVie | Phase 2 | Recruiting | Upper Facial Lines, Glabellar Lines | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871513) |
| October 7, 2026 | NCT07862764 | A Study to Assess Change in Disease State and Adverse Events in Korean Adult Patients With Relapsed or Refractory Diffuse Large B-Cell... | AbbVie | Observational | Not yet recruiting | Diffuse Large B-Cell Lymphoma | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07862764) |
| October 5, 2026 | NCT07856706 | A Single Ascending Dose, and Food Effect Study of ABBV-7828 in Healthy Adults | AbbVie | Phase 1 | Recruiting | Healthy Subjects | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856706) |
| September 28, 2026 | NCT07843693 | A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers | AbbVie | Phase 1 | Recruiting | Healthy Volunteers | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843693) |
| September 22, 2026 | NCT07832708 | Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults | AbbVie | Phase 1 | Not yet recruiting | Healthy Volunteers | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832708) |
| September 16, 2026 | NCT07821684 | A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR... | AbbVie | Phase 3 | Not yet recruiting | Non-Squamous Non-Small Cell Lung Cancer | 660 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821684) |
| September 8, 2026 | NCT07807956 | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With... | AbbVie | Phase 1 | Recruiting | Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer... | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807956) |
| August 31, 2026 | NCT07794891 | Study to Assess Participant Satisfaction After Jawline and Neck Treatment | AbbVie | Phase 4 | Recruiting | Jawline and Neck Appearance | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794891) |
| August 31, 2026 | NCT07794878 | Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial... | AbbVie | Phase 3 | Recruiting | Nasolabial Folds | 288 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794878) |
| August 28, 2026 | NCT07793422 | Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide... | AbbVie | Phase 3 | Not yet recruiting | Amyloid Light Chain (AL) Amyloidosis | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793422) |
| August 19, 2026 | NCT07772492 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata | AbbVie | Phase 3 | Recruiting | Severe Alopecia Areata | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772492) |
| August 18, 2026 | NCT07769502 | A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults... | AbbVie | Phase 2 | Recruiting | Pancreatobiliary Cancers, Pancreatic Ductal Adenocarcinoma | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769502) |
| August 10, 2026 | NCT07756645 | A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line... | AbbVie | Phase 3 | Recruiting | Non-Small Cell Lung Cancer | 940 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07756645) |
| August 10, 2026 | NCT07756580 | A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of... | AbbVie | Phase 1 | Active not recruiting | Glabellar Lines | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07756580) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 250 |
| Phase 1/2 | 22 |
| Phase 2 | 161 |
| Phase 2/3 | 22 |
| Phase 3 | 259 |
| Phase 4 | 30 |
| Not applicable | 18 |
| Observational | 214 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 601 |
| Recruiting | 110 |
| Active not recruiting | 109 |
| Terminated | 90 |
| Withdrawn | 27 |
| Not yet recruiting | 15 |
| No longer available | 12 |
| Enrolling by invitation | 5 |
| Available | 4 |
| Unknown | 1 |
| Temporarily not available | 1 |
| Approved for marketing | 1 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 129 |
| Hepatitis C | 73 |
| Hepatitis C, Chronic | 71 |
| Psoriasis | 46 |
| Arthritis, Rheumatoid | 46 |
| Crohn Disease | 46 |
| Leukemia, Myeloid, Acute | 40 |
| Colitis, Ulcerative | 40 |
| Carcinoma, Non-Small-Cell Lung | 35 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 31 |
| Dermatitis, Atopic | 31 |
| Parkinson Disease | 30 |
| Multiple Myeloma | 30 |
| Recurrence | 27 |
| Arthritis, Psoriatic | 25 |
| Ovarian Neoplasms | 21 |
| Migraine Disorders | 20 |
| Small Cell Lung Carcinoma | 18 |
| Lymphoma, Non-Hodgkin | 17 |
| Colorectal Neoplasms | 16 |
| Fibrosis | 15 |
| Spondylitis, Ankylosing | 15 |
| Arthritis | 15 |
| Hidradenitis Suppurativa | 15 |
| Squamous Cell Carcinoma of Head and Neck | 14 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Kitchen remodelers in the United States](https://specstream.ai/data/businesses/kitchen-remodelers/united-states)
- [Logging contractors in the United States](https://specstream.ai/data/businesses/logging-contractors/united-states)
- [Mental health clinics in the United States](https://specstream.ai/data/businesses/mental-health-clinics/united-states)
- [Nursing schools in the United States](https://specstream.ai/data/businesses/nursing-schools/united-states)
- [Paper mills in the United States](https://specstream.ai/data/businesses/paper-mills/united-states)
- [Pipe suppliers in the United States](https://specstream.ai/data/businesses/pipe-suppliers/united-states)
